Semaglutide is in clinical development for the treatment of overweight or obesity in patients with cardiovascular disease (CVD). Obesity is a long-term (chronic) health condition that progresses over time and is commonly defined by excess body fat (adipose tissue) that may impair health. Obesity is associated with a higher risk of developing serious diseases, including […]
Rivaroxaban and aspirin are drugs that reduce blood clots in blood vessels and are currently being given to some patients with CAD and PAD. The combination of rivaroxaban with aspirin is being developed as a more effective treatment. If licensed, this combination will offer a new option for the prevention of major cardiovascular events.
Cardiovascular disease (CVD) is a general term that refers to all conditions affecting the heart and blood vessels (circulation). These include angina, heart attack (also known as myocardial infarction), heart failure, stroke, and a number of diseases that affect the blood vessels. CVD is usually associated with a build-up of fatty deposits inside the blood […]
